ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.75321
0.13%
Brent Oil
83.625
-0.85%
Bitcoin
62,679.29
-3.35%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. CytomX Therapeutics Inc (CTMX)

  7. CytomX Therapeutics Inc (CTMX) Noticias

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CTMX
FechaHoraFuenteTítuloSímboloCompañía
22/06/202008:00GlobeNewswire Inc.CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Mye...NASDAQ:CTMXCytomX Therapeutics Inc
19/06/202011:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CTMXCytomX Therapeutics Inc
29/05/202016:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CTMXCytomX Therapeutics Inc
29/05/202007:02GlobeNewswire Inc.CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program...NASDAQ:CTMXCytomX Therapeutics Inc
28/05/202015:05GlobeNewswire Inc.CytomX Therapeutics to Participate at Upcoming Healthcare ConferencesNASDAQ:CTMXCytomX Therapeutics Inc
26/05/202007:00GlobeNewswire Inc.CytomX Therapeutics to Host Conference Call and Webcast to Review ASCO ASCO20 Virtual Scientific Program PresentationsNASDAQ:CTMXCytomX Therapeutics Inc
13/05/202016:19GlobeNewswire Inc.CytomX Therapeutics Announces Details of Presentations at the American Society of Clinical Oncology ASCO20 Virtual Scientific...NASDAQ:CTMXCytomX Therapeutics Inc
07/05/202015:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CTMXCytomX Therapeutics Inc
07/05/202015:10GlobeNewswire Inc.CytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
05/05/202007:00GlobeNewswire Inc.CytomX Therapeutics to Present at the 2020 Bank of America Securities Health Care ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
29/04/202017:49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CTMXCytomX Therapeutics Inc
29/04/202015:35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CTMXCytomX Therapeutics Inc
29/04/202015:33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CTMXCytomX Therapeutics Inc
29/04/202015:05GlobeNewswire Inc.CytomX Therapeutics Announces Presentations at the 2020 American Society of Clinical Oncology Virtual Scientific ProgramNASDAQ:CTMXCytomX Therapeutics Inc
28/04/202015:05GlobeNewswire Inc.CytomX Therapeutics Appoints Halley E. Gilbert to Board of DirectorsNASDAQ:CTMXCytomX Therapeutics Inc
27/04/202007:00GlobeNewswire Inc.CytomX Therapeutics to Announce First Quarter 2020 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
17/04/202015:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CTMXCytomX Therapeutics Inc
30/03/202015:15GlobeNewswire Inc.CytomX Therapeutics Announces Milestone Achievement in AbbVie CD71 Partnership and Provides Update on Impact of COVID-19 on ...NASDAQ:CTMXCytomX Therapeutics Inc
25/03/202015:02GlobeNewswire Inc.CytomX Therapeutics Announces New Employment Inducement GrantNASDAQ:CTMXCytomX Therapeutics Inc
23/03/202019:00GlobeNewswire Inc.CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies ...NASDAQ:CTMXCytomX Therapeutics Inc
23/03/202015:02GlobeNewswire Inc.CYTOMX THERAPEUTICS ANNOUNCES APPOINTMENT OF CARLOS CAMPOY AS CHIEF FINANCIAL OFFICERNASDAQ:CTMXCytomX Therapeutics Inc
06/03/202016:30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CTMXCytomX Therapeutics Inc
27/02/202016:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CTMXCytomX Therapeutics Inc
27/02/202016:33Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CTMXCytomX Therapeutics Inc
27/02/202016:09Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CTMXCytomX Therapeutics Inc
27/02/202015:28GlobeNewswire Inc.CytomX Therapeutics Announces Full-Year 2019 Financial Results and Provides Business UpdateNASDAQ:CTMXCytomX Therapeutics Inc
25/02/202007:00GlobeNewswire Inc.CytomX Therapeutics to Present at Cowen and Company 40th Annual Health Care ConferenceNASDAQ:CTMXCytomX Therapeutics Inc
24/02/202007:00GlobeNewswire Inc.Bristol-Myers Squibb Advances CytomX Therapeutics’ Anti-CTLA-4 Probody Therapeutic BMS-986249 into Randomized Cohort Expans...NASDAQ:CTMXCytomX Therapeutics Inc
20/02/202007:00GlobeNewswire Inc.CytomX Therapeutics to Announce Fourth Quarter 2019 Financial ResultsNASDAQ:CTMXCytomX Therapeutics Inc
14/02/202015:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CTMXCytomX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CTMX

Su Consulta Reciente

SPI
SP500
S&P 500
COIN
SOLUSD
Solana
NYSE
NKE
Nike
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
FX
USDMXN
US Dollar vs MXN
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
CCOM
US500
US 500
CCOM
OILBRENT
Brent Oil
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados